Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials

Corresponding Author

Claus Bachert MDPhD

Ghent University, Ghent, Belgium

Karolinska Institutet, Stockholm, Sweden

Sun Yat-sen University, The First Affiliated Hospital, Guangzhou, China

Correspondence

Claus Bachert MD, PhD, Upper Airways Research Laboratory, ENT Department, University Hospital Ghent, C. Heymanslaan 10 9000, Ghent, Belgium

Email: Claus.Bachert@UGent.be

Search for more papers by this author

留言 (0)

沒有登入
gif